News Articles
Latest articles, insights, and updates from the blog.
Contact Ketamine Resource
Send corrections, partnership questions, or advertising inquiries.
State-Level Ketamine Therapy Regulations: 2025 Landscape
State-by-state ketamine therapy rules for 2025: telehealth prescribing, in-person visit triggers, supervision, and compounding limits — what changed and where.
The Rise of At-Home Ketamine Treatment Companies
Major at-home ketamine therapy companies compared by dose, monitoring, published outcomes, and pricing — and the safety questions to ask before you enroll.
Key Ketamine Research Developments in 2025
Ketamine research highlights from 2025: TRD trials, BPL-003 phase 2a, measurement-based care data, telehealth outcomes, and what shifted in clinical practice.
FDA Esketamine (Spravato) Updates
A summary of the latest FDA regulatory actions, label updates, and clinical developments related to esketamine (Spravato) for depression treatment.
Ketamine Insurance Coverage: 2025 Trends and Developments
Ketamine insurance coverage in 2025: Spravato payer trends, off-label IV claim outcomes, prior-auth patterns, and what coverage gaps patients still face.
Telehealth Ketamine: Evolving Regulations
Telehealth ketamine prescribing rules in 2025: DEA Ryan Haight extensions, in-person visit triggers, dose limits, and the state variations patients hit.
International Ketamine Research: Global Developments and Discoveries
A roundup of significant ketamine research from around the world, including clinical trials, regulatory developments, and scientific discoveries outside the United States.